AU5006693A - Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors - Google Patents

Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors

Info

Publication number
AU5006693A
AU5006693A AU50066/93A AU5006693A AU5006693A AU 5006693 A AU5006693 A AU 5006693A AU 50066/93 A AU50066/93 A AU 50066/93A AU 5006693 A AU5006693 A AU 5006693A AU 5006693 A AU5006693 A AU 5006693A
Authority
AU
Australia
Prior art keywords
carboxylate
polyhydroxylated
isoquinolyl
quinolyl
naphthyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50066/93A
Inventor
Terrence R. Burke Jr.
Ivan Horak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU5006693A publication Critical patent/AU5006693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/66Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems and singly-bound oxygen atoms, bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
AU50066/93A 1992-08-07 1993-08-09 Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors Abandoned AU5006693A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US925762 1986-10-31
US92576292A 1992-08-07 1992-08-07
PCT/US1993/007575 WO1994003432A1 (en) 1992-08-07 1993-08-09 Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors

Publications (1)

Publication Number Publication Date
AU5006693A true AU5006693A (en) 1994-03-03

Family

ID=25452196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50066/93A Abandoned AU5006693A (en) 1992-08-07 1993-08-09 Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors

Country Status (2)

Country Link
AU (1) AU5006693A (en)
WO (1) WO1994003432A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648378A (en) * 1995-06-07 1997-07-15 Research Corporation Technologies, Inc. 2-iminochromene derivatives as inhibitors of protein tyrosine kinase
AU727708B2 (en) 1996-06-20 2000-12-21 Board Of Regents, The University Of Texas System Compounds and methods for providing pharmacologically active preparations and uses thereof
WO1998014211A1 (en) * 1996-10-01 1998-04-09 Celltech Therapeutics Limited Pharmaceutical products containing protein-tyrosine kinase inhibitors and anti-cd4 antibodies
US7964732B2 (en) 2006-11-17 2011-06-21 Pfizer Inc. Substituted bicyclocarboxyamide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04154736A (en) * 1990-10-16 1992-05-27 Green Cross Corp:The Naphthalene derivative

Also Published As

Publication number Publication date
WO1994003432A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
AU2874889A (en) Quinoline, quinazoline, and cinnoline derivatives
AU6325086A (en) Surgical clip, applier, and method
AU4422293A (en) Substituted 2-amidotetralins as melatonin agonists and antagonists
AU2396897A (en) 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
AU9795098A (en) 2,3-benzodiazepin-2-one derivatives, their preparation and their use as inhibi tors of protein tyrosine kinases
NO932176L (en) QUINOLINE, NAFTYRIDINE AND PYRIDOBENZOCSAZINE DERIVATIVES
DK0877734T3 (en) Quinoline and quinazoline compounds useful in therapy
AU2362595A (en) Novel megakaryocytic protein tyrosine kinases
NO944187D0 (en) Isoquinolines, Methods for their Preparation and Use
ZA899725B (en) N-aryl-azetidinones,their preparation process and their use as elastage inhibitors
NO900613D0 (en) PROCEDURE FOR THE PREPARATION OF ACTIVATED CHITOSANES AND USE IN THE PREPARATION OF CHITOSANDER DERIVATIVES.
NO920222L (en) PROCEDURE FOR THE PREPARATION OF QUINOLINE, PYRIDINE AND IMIDAZOLD DERIVATIVES, AND VARIOUS SUCH DERIVATIVES
ZA899076B (en) (1h-azol-1-ylmethyl)substituted quinoline,quinazoline or quinoxaline derivatives
AP9400706A0 (en) Indole derivatives, method of preparation and use
AU2779589A (en) Isoquinoline derivatives, their preparation and their use
DK0562583T3 (en) Novel alkylenediamonium diclavulanate derivatives, process for their preparation and use thereof
IL114418A0 (en) Tumor necrosis factor receptor-II associated protein kinase and methods for its use
AU7400091A (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
NO892057D0 (en) PSYLLIUM PREPARATION AND PROCEDURE FOR PREPARING IT.
AU1364092A (en) Amino-substituted pyrimidines, derivatives and methods of use therefor
AU3066697A (en) 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and the ir use as protein kinase c (=pkc) modulators
FI941914A (en) 2-amino-4-quinoline dihydropyridines, methods for their preparation and their use
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU5006693A (en) Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors
AU681204B2 (en) N-substituted azabicycloalkane derivatives, their preparation and use